Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
Company: PerkinElmer Informatics
Bioinformatics Products Strategist & Manager, PerkinElmer, Madrid, Spain. With more than eighteen years of experience in bioinformatics, he is focused on addressing current challenges in omics data analysis and integration.
Email Eduardo Gonzalez, Ph.D.
Your Email:
Your Full Name:
Message :